The Pharma Data

MAY 6, 2021

Under the MoU, the companies and the IOC will coordinate with National Olympic Committees (NOCs) around the world to understand and work to help address the local need for vaccine doses for national delegations’ participation in the Games. This press release features multimedia. View the full release here: [link].

Vaccine 52

Vaccine Clinical Trials Licensing Licensing 52

Drug Discovery Today

APRIL 7, 2020

OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak

Vaccine 100

Vaccine Research 100

The Pharma Data

FEBRUARY 8, 2021

Q4 2020 sales growth (2) of 4.2% Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. Full-year 2020 performance. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. and business EPS growth of 9.8% to €982 million).

Vaccine 52

Vaccine Production FDA Therapies 52

The Pharma Data

JANUARY 21, 2021

Percent of Kindergarteners Not Up to Date With MMR in 2019-2020. percent of kindergarteners were not up to date with measles, mumps, and rubella (MMR) vaccination and did not have an exemption in the 2019 to 2020 school year, according to research published in the Jan. The researchers found that vaccination coverage was 94.9,

Vaccine 52

Vaccine Disease Research 52

Eye on FDA

MARCH 5, 2023

Note these numbers cover meetings about drug applications only, not including vaccines or cellular therapies. That said, beginning in 2020 meetings began skewing to more negative outcomes and 2022 was the first year where the number of negative outcomes outweighed the number of positive outcomes.

FDA 72

FDA Vaccine Drugs Therapies 72

The Pharma Data

FEBRUARY 4, 2021

Q4 2020 sales growth (2) of 4.2% Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. Full-year 2020 performance. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. and business EPS growth of 9.8% to €982 million).

Vaccine 52

Vaccine Production FDA Therapies 52

The Pharma Data

JUNE 29, 2021

Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. “During the COVID-19 pandemic, mRNA technologies demonstrated potential to deliver new vaccines faster than ever before. . ” said Thomas Triomphe, Executive Vice President, Global Head of Sanofi Pasteur.

Vaccine 52

Vaccine Disease International Treatment 52

The Pharma Data

JULY 8, 2021

People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites, including Salt Lake City. Those who unfortunately got COVID-19 despite being vaccinated were still better off than those who didn’t.”

Vaccine 52

Vaccine Virus Nurses Hospitals 52

The Pharma Data

NOVEMBER 9, 2020

DAEGU, KOREA, November 09, 2020 /24-7PressRelease/ — South Korean religious group Shincheonji Church of Jesus has announced their third convalescent plasma donation drive to take place for 3 weeks starting November 16th at an Indoor Athletics Center in Daegu. Approximately 4,000 members of the group are expected to participate.

Treatment 145

Treatment Vaccine Disease 145

The Pharma Data

MAY 13, 2021

Product Name: 2020 New Weight Loss Offer! Click here to get 2020 New Weight Loss Offer! 2020 New Weight Loss Offer! Description: Click here to get 2020 New Weight Loss Offer! 2020 New Weight Loss Offer! is backed with a 60 Day No Questions Asked Money Back Guarantee.

Production 52

Production Vaccine 52

The Pharma Data

JULY 15, 2021

FreVAX is an innovative intramuscular needle free vaccine injection device for pigs around weaning until the end of nursery. FreVAX intramuscular needle free device has been available since December 2020 to swine producers globally. billion euros in 2020 and presence in more than 150 countries. The FreVAX app 2.0

Vaccine 52

Vaccine Compliance Disease 52

The Pharma Data

JUNE 26, 2021

Sanofi and Translate Bio initiate Phase 1 clinical trial of mRNA influenza vaccine. The trial will evaluate the safety and immunogenicity of a monovalent flu vaccine candidate coding for the hemagglutinin protein of the A/H3N2 strain of the influenza virus. JUNE 22 , 2021. We look forward to sharing initial results by year-end. ”. “

Clinical Trials 52

Clinical Trials Vaccine Trials Immune Response 52

The Pharma Data

JUNE 25, 2021

In the unprecedented context of at least 13 variants circulating within the study population subset assessed at this interim analysis, CVnCoV demonstrated an interim vaccine efficacy of 47% against COVID-19 disease of any severity and did not meet prespecified statistical success criteria. About CVnCoV.

Vaccine 52

Vaccine Trials Immune Response Virus 52

The Pharma Data

MAY 3, 2021

The European Medicines Agency (EMA) is evaluating an application submitted by Pfizer and BioNTech for use of their COVID-19 vaccine in children aged 12 to 15 years. . The vaccine has been authorized by the EU for use in people 16 years and up since December 2020. . The companies look forward to working closely with the U.S.

Vaccine 52

Vaccine RNA Clinical Trials Packaging 52

The Pharma Data

JUNE 24, 2021

The primary objective in the trial is to describe safety when both vaccines are co-administered, with follow up six months after vaccination. Secondary objectives are to describe immune responses produced by each of the vaccines. Secondary objectives are to describe immune responses produced by each of the vaccines.

Vaccine 52

Vaccine Immune Response FDA Licensing 52

The Pharma Data

MARCH 11, 2021

(NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2), underscoring the observed substantial public health impact of Israel’s nationwide immunization program.

Vaccine 52

Vaccine Clinical Trials Hospitals Licensing 52

DrugBaron

NOVEMBER 9, 2020

The first death unequivocally caused by COVID was reported to the world on January 11 th 2020 – that’s just 303 days ago (even if it feels like a lifetime away). Indeed, China has already licensed a vaccine, albeit without the data that would typically be required to support such an approval.

Vaccine 100

Vaccine Pharmaceutical Companies Government Pharmaceuticals 100

The Pharma Data

JANUARY 25, 2021

In a surprise move, Merck announced that it is giving up on its two coronavirus vaccine candidates after seeing a subpar immune response and shifting its focus to a pair of investigational coronavirus treatments. 24, 2020 ). 28, 2020 ). The drugmaker’s decision coincides with a tightening of vaccine supplies in the U.S.

Vaccine 52

Vaccine Immune Response Trials Clinical Trials 52

The Pharma Data

JANUARY 22, 2021

As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic.

Vaccine 52

Vaccine Immune Response Government RNA 52

The Pharma Data

SEPTEMBER 5, 2021

million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines. “The world is relying on safe and effective vaccines to bring an end to the COVID-19 pandemic. The study reported findings from mid-December 2020 through June 26, 2021. The total number of people evaluated was 6.2

Vaccine 52

Vaccine Clinical Trials Research Virus 52

The Pharma Data

MARCH 24, 2021

billion EUR in 2020 (18.9% Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for which no satisfactory treatments are available. Our achievements in 2020 are the result of their effort.”. Overall R&D investment up 7% to 3.7

Therapies 52

Therapies Disease Vaccine Small Molecule 52

The Pharma Data

JANUARY 29, 2021

Adults Want the COVID-19 Vaccine as Soon as Possible. adults are increasingly eager to get the COVID-19 vaccine, according to survey results released by the Kaiser Family Foundation (KFF) COVID-19 Vaccine Monitor. 8, 2020, and included a nationally representative random-digit dial telephone sample of 1,676 adults.

Vaccine 52

Vaccine 52

PPD

MAY 11, 2023

The global COVID-19 pandemic increased awareness of the importance of vaccine development — both for drug developers and the public. The speed at which COVID-19 vaccines were developed was remarkable, but like most newly developed vaccines, there was variation among who could receive the shots and when.

Vaccine 52

Vaccine Clinical Trials Long-Term Care Facilities Trials 52

The Pharma Data

MARCH 8, 2021

Valneva SE (“Valneva”), a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. As announced in December 2020 1 , VLA15-221 is a randomized, observer-blind, placebo-controlled Phase 2 study. We are excited to be part of the Lyme disease vaccine development program with Valneva.

Vaccine 52

Vaccine Disease Protein Expression Trials 52

The Pharma Data

FEBRUARY 22, 2021

Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate. If results are positive, Phase 3 study to start in Q2 2021, with vaccine expected to be available in Q4 2021. This new Phase 2 study will enable us to identify the final vaccine formulation for adults of all ages.

Vaccine 52

Vaccine Immune Response Trials Clinical Trials 52

The Pharma Data

JANUARY 20, 2021

20, 2021 — The coronavirus pandemic hit dental practices hard early in 2020, as COVID-19 fears kept millions of Americans from seeking routine oral health care. But hope is in sight as dentists are being included in the first wave of recipients for COVID-19 vaccines. WEDNESDAY, Jan.

Vaccine 52

Vaccine Doctors Virus Disease 52

Eye on FDA

MARCH 26, 2021

The last in-person meeting of an advisory committee – by coincidence a meeting of the Vaccines and Related Biological Products Advisory Committee – occurred on March 4, 2020. I recently attended all three Vaccines and Related Biological Products Advisory Committee meetings on the COVID-19 vaccine candidates.

Vaccine 96

Vaccine FDA Engineering Virus 96

The Pharma Data

OCTOBER 7, 2021

COVID-19 vaccines are highly effective in preventing symptomatic illness among health care workers in real-world settings. For those who received the two-dose regimen of the Moderna vaccine, the risk was reduced by 96%. The vaccines’ effectiveness was, however, lower in immunocompromised people.

Vaccine 52

Vaccine Disease Research 52

The Pharma Data

MARCH 11, 2021

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio (NASDAQ: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company, today announced the start of the Phase 1/2 clinical trial for MRT5500, an mRNA vaccine candidate against SARS-CoV-2, the virus that causes COVID-19.

Clinical Trials 52

Clinical Trials Vaccine Trials Immune Response 52

National Drug & Alcohol Research Centre Blog

FEBRUARY 24, 2022

Olivia Price It has been one year since the COVID-19 vaccine rollout commenced in Australia, and while vaccination rates initially lagged behind other countries, over 95% of Australians aged 12 years and older are now fully vaccinated. We tend to consider the remaining unvaccinated people a homogenous ‘anti-vax’ group.

Vaccine 52

Vaccine Drugs Disease Pharmaceuticals 52

The Pharma Data

MAY 14, 2021

Product Name: Sweet Freedom – New Detox & Weight Loss Program For 2020! Click here to get Sweet Freedom – New Detox & Weight Loss Program For 2020! Sweet Freedom – New Detox & Weight Loss Program For 2020! Sweet Freedom – New Detox & Weight Loss Program For 2020!

Production 52

Production Vaccine 52

The Pharma Data

APRIL 1, 2021

Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine. Sanofi announces investment of more than €600 million to build a new vaccine facility in Toronto to increase supply of its differentiated influenza vaccines in Canada, the United States and Europe.

Vaccine 52

Vaccine Government Science Production 52

The Pharma Data

JULY 21, 2021

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. Valneva and Pfizer entered into a collaboration agreement in April 2020 to co-develop VLA15 2.

Vaccine 52

Vaccine Disease Trials Protein Expression 52

The Pharma Data

APRIL 3, 2021

Johnson & Johnson (the Company) has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Janssen’s COVID-19 Vaccine Candidate.

Clinical Trials 52

Clinical Trials Vaccine Trials Immune Response 52

The Pharma Data

NOVEMBER 17, 2021

AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the last 11 months. 2) From the body of evidence in clinical trials and real-world data, the vaccine has been shown to have an acceptable safety profile.(3,4,5,6,7).

Vaccine 52

Vaccine Clinical Trials Virus Licensing 52

The Pharma Data

MAY 14, 2021

Product Name: Home – Beat Kidney Disease – 2020 – Beat Kidney Disease. Home – Beat Kidney Disease – 2020 – Beat Kidney Disease is backed with a 60 Day No Questions Asked Money Back Guarantee.

Disease 52

Disease Production Licensing Licensing 52

The Pharma Data

MAY 15, 2021

Product Name: Fat Burning Fingerprint- 2020 New Funnel With Massive Aov Boost! Click here to get Fat Burning Fingerprint- 2020 New Funnel With Massive Aov Boost! Fat Burning Fingerprint- 2020 New Funnel With Massive Aov Boost! Description: Click here to get Fat Burning Fingerprint- 2020 New Funnel With Massive Aov Boost!

Production 52

Production Vaccine 52